Key Topics
Terms and concepts identified from this document
Scope & Applicability
Product Classes
4FDA intends to assess device cybersecurity based on a number of factors; demonstrate or maintain its safety and effectiveness; ensuring cybersecurity has become essential to FDA’s ability to protect the public health; Cyber-resiliency capabilities for medical devices
Generally recommended for Enhanced Documentation; Regulatory classification mentioned for implantable sensors and HPV tests; Mentioned in the context of an in vitro nucleic acid test for CMV DNA.
Devices subject to section 522 postmarket surveillance orders; devices subject to postmarket surveillance orders
Low risk medical devices
Stakeholders
9Entity responsible for submitting NDINs
Contract acceptor for transportation of APIs
Individual without direct responsibility for the design stage under review
Personnel who identify customer needs and create concept documents.
Individuals responsible for translating user needs into engineering requirements.
External resources that may be involved in the design process.
Entities eligible to request AMT designation
Senior management responsible for quality policy
involved in considering applicant concerns if present at the meeting
Regulatory Context
Regulatory Activities
3Method used by FDA to assist in understanding regulations
Tattoo ink firms conducted voluntary ink recalls due to microbial contamination
monitoring growth and pubertal development in clinical trials
Document Types
10IEC IRB Consent Form List in eCTD
Documentation of changes made to the design.
The results of a design effort at each design phase.
Records of physical and performance requirements of a device.
Critical design information mentioned in a case study regarding maintenance and validation.
Records maintained by engineers that may form part of the design history.
Approved plan that the design development must follow.
Index of documents defining the product or process
Document issued to implement a specific revision to a document
Document used to identify a design problem for correction
Attributes
7Potential outcome of scheduling pressures and poor planning.
Simulation of temperature, humidity, shock, and vibration during validation
Basis for design validation
Characteristics critical to compatibility with external systems and users.
Specifications regarding speed, strength, accuracy, and limits of operation.
Specifications of what the device does and its operational capabilities.
Evidence of a new intended use based on communications
Technical Details
Testing Methods
10Project management tool (PERT) used for planning complex projects.
Method used to establish clinical association.; Method for generating new evidence for clinical validation
Verification of packaging
Verification that components are derated properly
Used for characterization of physical forms.
Testing performed on final finished product
Should be performed on the sterilized finished product simulating clinical use.
Analysis to identify potential failure modes of a DHT
Verification method for process or design
Specialized assessment to verify performance under stress
Processes
10Activity to ensure cybersecurity changes do not impact safety
Requirement for class II and class III devices
Identification of potential sources of error for a device
Ensures inputs and outputs are appropriate for assay requirements
Procedures used to manage system updates and subsequent validation.
Documented, comprehensive, systematic examination of a design; Overlaps with verification and validation
Activity to ensure cybersecurity changes do not impact effectiveness
Process to confirm that design output meets design input requirements.
Process to ensure devices conform to defined user needs and intended uses.
Design successfully transferred into production
Clinical Concepts
2Context for the sample consent form
enhanced understanding of the degree of conformance of a design to user and patient needs
Identified Hazards
Hazards
5Inherent risks in the design process that planning aims to mitigate.
Risks arising from unverified design changes late in the cycle
A type of EM disturbance that can degrade device performance
Problems intended to be detected early through formal reviews
A performance and safety concern to be addressed in design inputs.
Standards & References
External Standards
1citations should be reviewed for completeness and relevance
Specifications
8Design control begins with development and approval of design inputs; Requirements that design output must meet
Documents and articles used to manufacture production devices
validate computer software used as part of production or the quality system for its intended use
Basis against which design validation is performed
Result of the design process to be verified
Established for components to meet overall dimensional specifications
limits for solid state form and particle size; Tightening acceptance criteria; Numerical limits or ranges for tests
Description of any Pass/Fail criteria specific to the device beyond the requirements specified in the standard
Related CFR Sections (1)
- 21CFR820.3§ 820.3 Definitions.
The definitions in ISO 13485 and in Clause 3 of ISO 9000 (incorporated by reference, see § 820.7 ) apply to this part, except as specified in paragraph (b) of this section, and do not affect the meaning of similar terms defined in this title.Read full regulation →
Enforcement Impact
Deficiencies cited in Warning Letters referencing the same regulations
Recent Cases
- 2026-02-24
CGMP/QSR/Medical Devices/Adulterated
Beta Bionics, Inc.
- 2025-12-09
CGMP/QSR/Medical Devices/Adulterated
Envoy Medical Inc.
- 2025-11-25
CGMP/QSR/Medical Devices/Adulterated
Hong Qiangxing Shenzhen Electronics Limited
- 2025-10-28
CGMP/QSR/Medical Devices/Adulterated
Contec Medical Systems Co., Ltd.
- 2025-10-28
CGMP/QSR/Medical Devices/Adulterated/Misbranded
Royal Philips
Related Warning Letters (10)
- 2026-02-24
CGMP/QSR/Medical Devices/Adulterated
Beta Bionics, Inc.
- 2025-12-09
CGMP/QSR/Medical Devices/Adulterated
Envoy Medical Inc.
- 2025-11-25
CGMP/QSR/Medical Devices/Adulterated
Hong Qiangxing Shenzhen Electronics Limited
- 2025-10-28
CGMP/QSR/Medical Devices/Adulterated
Contec Medical Systems Co., Ltd.
- 2025-10-28
CGMP/QSR/Medical Devices/Adulterated/Misbranded
Royal Philips
- 2025-10-28
CGMP/QSR/Medical Devices/Adulterated/Misbranded
Qianjiang Kingphar Medical Material Co Ltd.
- 2025-10-21
CGMP/QSR/Medical Devices/Adulterated
LEVO AG
- 2025-10-07
CGMP/QSR/Medical Devices/Adulterated
Technological Medical Advancements LLC
- 2025-09-23
Medical Device/Adulterated/Misbranded/Lacks PMA and/or 510(k)
The Richline Group, Inc.
- 2025-09-16
Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA) Adulterated Device
SeniorLife Technologies, Inc.
Related MFDS Guidelines
Korean regulatory guidelines covering similar topics
See Also (8)
- Content of Premarket Submissions for Device Software Functions: Guidance for Industry and Food and Drug Administration Staff (Status: Final)
- CPG Sec. 300.600 Commercial Distribution with Regard to Premarket Notification (Section 510(k)) (Status: Final)
- CPG Sec. 350.100 Packaging Technologies and Tamper-Resistant Packaging Requirements for Contact Lens Solutions and Tablets (Status: Final)
- CPG Sec. 310.100 Pacemaker Reuse (Status: Final)
- Hysteroscopic and Laparoscopic Insufflators: Submission Guidance for a 510(k) (Status: Final)
- Kit Certification for 510(k)s (Status: Final)
- Immunotoxicity Testing Guidance (Status: Final)
- Inspection and Field Testing of Radiation-Emitting Electronic Products: Attachment C: Specific Instructions for Sunlamp Product Inspections and Tests (Status: Final)